Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California. It applies cell and gene therapy to combat haemophilia and other genetic diseases. From Wikipedia
Sangamo regains rights to its hemophilia A gene therapy but faces uncertainty after Pfizer's withdrawal despite strong Phase III trial results.
